Journal Article Summary
The article investigates the availability, costs, and accessibility of cancer medications in countries outside of Europe, highlighting a critical issue in global health. Access to effective and affordable cancer treatments is essential for successful cancer control and management, especially as cancer rates rise worldwide. The study aims to shed light on disparities in access to these vital medications, particularly in low- and middle-income countries, where the burden of cancer is often greatest but resources are limited.
To gather data, researchers conducted an online survey involving 135 reporters from 63 countries, assessing the formulary availability of licensed cancer drugs, patient out-of-pocket costs, and the actual accessibility of these medications with valid prescriptions. The findings revealed significant disparities: many cancer drugs, including those on the World Health Organization's Model List of Essential Medicines, were either unavailable or only accessible at full cost in lower-income countries. For instance, in low-middle-income countries, 32% of essential medicines were available only at full price, while in low-income countries, this figure rose to 58%. The study highlighted that new, expensive targeted therapies were even less accessible in these regions compared to wealthier nations.
Despite the comprehensive nature of the study, there are limitations to consider. The data reflects a snapshot in time and may not account for newer treatments introduced after the survey period. Additionally, the accuracy of the findings relies on the reporting of individual clinicians and pharmacists, which can vary. Patients and caregivers should discuss these findings with healthcare professionals to understand their local context and explore options for accessing necessary cancer treatments, as well as to address any concerns about the affordability and availability of medications.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Cherny N I, Sullivan R, Torode J, Saar M, Eniu A. ESMO International Consortium Study on the availability, out-of-pocket costs and accessibility of antineoplastic medicines in countries outside of Europe. Annals of Oncology 2017. DOI: 10.1093/annonc/mdx521. PMID: 28950323. PMCID: PMC5834140.
Featured Pill Pals Product
Acetaminophen 500 MG Caplets ---1,000 Count --- Generic For Tylenol --- Major / Rugby --- Over The Counter
Acetaminophen 500 MG Caplets —1,000 Count — Generic For Tylenol — Major / Rugby — Over The Counter is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. This is an Over The Counter Product, so no prescription is required.However, your prescriber can still write for it as a prescription, if desired.
